Clinical outcomes indicate that nearly 60% of patients achieve sustained weight loss using GLP-1 therapies, further strengthening adoption rates
(2024) Use of Bremelanotide in men with sexual dysfunction at a sexual medicine clinic
10.1002/ptr.853 [DOI] [PubMed] [Google Scholar] 46.Steigerwalt R, Belcaro G, Cesarone MR, Di Renzo A, Grossi MG, Ricci A, et al
PlexusDx combines clinical evidence with genetic and biomarker insight to help you and your provider plan for long-term weight management sustainability
It has recently been reported that human GLP-1 analogues were more effective in reducing the occurrence of major adverse cardiovascular events, myocardial infarctions, and hospitalizations due to cardiovascular causes when compared to exendin-based GLP-1RAs [71]
While it doesn't belong to the GLP-1 class, it's often the first alternative or complement to drugs like Ozempic